Skip to main content
. 2024 May 6;121(20):e2318119121. doi: 10.1073/pnas.2318119121

Fig. 1.

Fig. 1.

Schematic description of nanotherapeutic technology for treating primary breast tumor and the secondary metastatic tumor in the brain using two brain accumulating NPs one with a chemotherapeutic platinum prodrug and the other with a glycolysis inhibitor to tackle metabolic flexibility by simultaneous disruption of OXPHOS and glycolysis and to overcome repair-induced resistance by attacking mitochondrial DNA.